$42.710
+1.427 (+3.34%)At close
STEP News
STEP Events
StepStone Group Appoints Yoshitaka Todoroki as Vice Chairman
StepStone Group announced that Yoshitaka Todoroki has joined the firm as a Vice Chairman, focusing on strategic initiatives in Japan and the broader Asia region. Most recently, Todoroki served as Executive Director of the Private Market Investment Department at Japan's Government Pension Investment Fund
Amulet Capital Closes Recapitalization of US Fertility
Amulet Capital Partners announced the closing of a recapitalization of US Fertility, the nation's leading fertility services platform, through a new continuation vehicle. StepStone Group acted as the sole lead investor, supported by other existing and new investors. Financial terms of the transaction were not disclosed. The transaction marks an important milestone for Amulet and US Fertility, reflecting Amulet's conviction in the company's long-term trajectory while positioning US Fertility to continue investing in growth, clinical innovation and its mission to expand access to advanced reproductive care nationwide. Amulet continues to be aligned around the company's physician-led model, clinical excellence and patient-first approach, and this expanded investor support broadens the base of long-term capital behind US Fertility and increases the financial resources available to support the company in its next phase of growth. US Fertility will continue to focus on expanding patient access to high-quality fertility care, investing in clinical outcomes through technology and data, strengthening collaboration among physicians, scientists and care teams, and pursuing strategic growth opportunities that advance the company's mission.
Company Reports Q1 Revenue of $300.6M
Reports Q1 revenue $300.6M, consensus $309.32M.
StepStone Reports Q4 Adjusted Revenue of $305.84M
Reports Q4 adjusted revenue $305.84M, consensus $292.11M. The company said, "Results for the quarter include $4 million of revenues from retroactive fees, primarily driven by StepStone's infrastructure secondaries and multi-strategy global venture capital funds. The prior year quarter included $16 million of retroactive fees."
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.






